Conversely, activating mutations of NPR2 result in longer bones (Miura et al., 2012; Hannema et al., 2013; Miura et al., 2014), opposite to what is seen with the AMDM patients. This evidence concerns the gene NPR2 and acromesomelic dysplasia 1, Maroteaux type.